알마즌닷컴

• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

P = 0.001, **p < 0.P019 Relation between adrenomedullin and short-term outcome in ICU patients: Results from the frog ICU study E. G. Gayat1, J. Struck2, A. Cariou3, N. Deye1, B. Guidet4, S. Jabert5, J. Launay1, M. Legrand6, M. L ne7, M. Resche-Rigon6, E. Vicaut1, A. Vieillard-Baron8, A. Mebazaa1 1 H ital Lenvatinib Lariboisi e, Paris, France; 2Sphingotec, Berlin, Germany; 3H ital Cochin, Paris, France; 4H ital Saint-Antoine, Paris, France; 5CHRU de Montpellier, Montpellier, France; 6H ital Saint-Louis, Paris, France; seven AP-HM, Marseille, France; 8H ital Ambroise Par? Paris, France Crucial Treatment 2016, 20(Suppl 2):P019 Introduction: Adrenomedullin (ADM) can be a peptide with 52 amino acids which has robust vasodilator exercise. Elevated plasma ADM stages are actually detected inside of a wide range of physiological and pathological problems, with PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/22763976 the very best elevations observed in septic shock. Marino et al. shown a robust affiliation of admission ADM amounts with the severity of sepsis, supporting an previously report describing elevated ADM degrees in those people with critical sepsis and people with septic shock [1]. By utilizing a novel assay distinct for bioactive ADM (bio-ADM) as Marino et al.the intention of the examine was to assess the relation concerning ADM calculated at admission and in-ICU mortality in consecutive clients regardless the reason for admission. Solutions: The French and euRopean Result reGistry in Intense Treatment Models (FROG-ICU) examine was a multicenter observational examine, such as 2087 consecutive patients followed up to a single yr for people who survived to ICU remain. The protocol has formerly been explained [2]. Plasma have been collected at admission for all individuals and at discharge for in-ICU survivors. ADM was calculated in all plasma using a sandwich assay specific for bio-ADM. The affiliation between inICU mortality and also the amount of ADM was assessed by univariate examination and modified assessment for severity at admission measured via the SAPS-II. Enhancement in place underneath the ROC curve and reclassification indices have been assessed. Outcomes: 2087 sufferers are already integrated, sixty five male by using a median age of sixty three (51-74), a median Charlson score of three (1-5) plus a median SAPS-II forty nine (36-63). Septic shock was current in 488 (23 ) people. Median (and interquartile assortment) of ADM in-ICU survivors and nonsurvivors was fifty seven pg/mL [30-114] and a hundred and ten pg/mL [63-220], respectively (p < 0.001). Hazard ratio of in-ICU death for patients with a level of ADM higher than the median value was 2.12 (95 CI: 1.73-2.60) and 1.68 (95 CI: 1.36-2.07) when adjusted for SAPS-II. Area under the ROC curve of SAPS-II was significantly improved by the addition of ADM (0.653 [0.624 - 0.682] to 0.702 [0.675 - 0.729], p = 0.01). Conclusions: In the present study, ADM was independently associated with in-ICU mortality and improved prognostic prediction. The clinical and therapeutic implication of these findings need to be further investigated.References [1] R Marino et al. Critical Care 2014, 18:R34 [2] Mebazaa et al. BMC Anesthesiology (2015) 15:P020 Impact of disease severity assessment on performance of heparinbinding protein for the prediction of septic shock R. Arnold1, M. Capan1, A. Linder2, P. Akesson2 1 Christiana Care Health System, Newark, USA; 2Skane University Hospital, Lund University, Lund, Sweden Critical Care 2016, 20(Suppl 2):PCritical Care 2016, Volume PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/9547713 twenty SupplPage twenty ofIntroduction: Prognostic biomarkers for sepsis are described no matter individual severity. Our objective was to desc.